Abstract
The hypothesis was tested that the operation of an ATP-dependent export pump localized at the apical (brush border) surface of the intestinal epithelium may limit substrate absorption kinetics. Human intestinal Caco-2 cell-layers display saturable secretion of vinblastine from basal to apical surfaces (K m, 18.99 ± 5.55 µM; V max, 1285.9 ± 281.2 pmol cm−2 hr−1) that is inhibited by verapamil, consistent with the expression of the ATP-dependent P-glycoprotein drug efflux pump at the apical brush border membrane. Inhibition of P-glycoprotein by a variety of modulators (verapamil, 1,9-dideoxyforskolin, nifedipine, and taxotere) is associated with an increased vinblastine absorptive permeability. Vinblastine absorption displayed a nonlinear dependence upon luminal (apical) vinblastine concentration, and vinblastine absorption increased markedly at concentrations where vinblastine secretory flux was saturated (>20 µM). Upon inhibition of P-glycoprotein by verapamil and 1,9-dideoxyforskolin, vinblastine absorption increased and was linearly dependent on vinblastine concentration. The limitation of P-glycoprotein substrate absorption by active ATP-dependent export via P-glycoprotein is discussed, together with the possibility that other classes of substrate may be substrates for different ATP-dependent export pumps.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
I. Pastan and M. M. Gottesman. Multidrug resistance. Annu. Rev. Med. 42:277–286 (1991).
J. M. Ford and W. N. Hait. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:155–199 (1990).
C. Cordon-Cardo, J. P. O'Brian, J. Boccia, J. R. Bertino, and M. R. Melamed. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumour tissues. J. Histochem. Cytochem. 38:1277–1287 (1990).
F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem. 37:159–164 (1989).
M. B. Meyers, K. W. Scotto, and F. M. Sirotnak. P-glycoprotein content and mediation of vincristine efflux: Correlation with the level of differentiation in luminal epithelium of mouse small intestine. Cancer Comm. 3:159–165 (1991).
J. Hunter, B. H. Hirst, and N. L. Simmons. Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein. Br. J. Cancer 64:437–444 (1991).
P. M. Dewick. Tumour inhibitors from plants. In W. C. Evans (ed.), Trease and Evans' Pharmacognosy, 13th ed., Balliesre Tindall, London, 1989, pp. 637–656.
W. R. Leib and W. D. Stein. Biological membranes behave as non-porous polymer sheets with respect to diffusion of nonelectrolytes. Nature 224:240–243 (1967).
P. A. Shore, B. B. Brodie, and C. A. M. Hogben. The gastric secretion of drugs: A pH partition hypothesis. J. Pharmacol. Exp. Ther. 119:361–369 (1957).
G. T. A. McEwan and M. L. Lucas. The effect of E.Coli STa enterotoxin on the absorption of weakly dissociable drugs from rat proximal jejunum in vivo. Br. J. Pharmacol. 101:937–943 (1990).
D. C. Taylor, J. Lynch, and D. E. Leahy. Models for intestinal permeability to drugs. In J. G. Hardy, S. S. Davis, and C. G. Wilson (eds.), Drug Delivery to the Gastrointestinal Tract, Ellis Horwood, Chichester, U.K., 1990 pp. 133–145.
M. Horio, K.-V. Chin, S. J. Currier, S. Goldenberg, C. Williams, I. Pastan, M. M. Gottesman, and J. Handler. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby kidney cell epithelia. J. Biol. Chem. 264:14880–14884 (1989).
J. Hunter, B. H. Hirst, and N. L. Simmons. Transepithelial vinblastine secretion mediated by P-glycoprotein is inhibited by forskolin derivatives. Biochem. Biophys. Res. Commun. 181:671–676 (1991).
A. R. Hilgers, R. A. Conradi, and P. S. Burton. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 7:902–910 (1990).
I. J. Hidalgo, T. J. Raub, and R. T. Borchardt. Characterisation of the human colon carcinoma cell-line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736–749 (1989).
P. Artursson and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Comm. 175:880–885 (1991).
M. Pinto, S. Robine-Leon, M. D. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. LaCroix, P. Simon-Assman, K. Haffen, J. Fogh, and A. Zweibaum. Enterocyte-like differentiation and polarisation of the human colon carcinoma line Caco-2 in culture. Biol. Cell. 47:323–330 (1983).
I. Mohrmann, M. Mohrmann, J. Biber, and H. Murer. Sodium dependent transport of Pi by an established intestinal epithelial cell-line (Caco-2). Am. J. Physiol. 250:G323–G330 (1986).
K. I. Inui, M. Yamamoto, and H. Saito. Transepithelial transport of oral cephalosporins by monolayers of intestinal cell-line Caco-2: Specific transport systems in the apical and basolateral membranes. J. Pharmacol. Exp. Ther. 261:195–201 (1992).
M. Horio, E. Lovelace, I. Pastan, and M. M. Gottesman. Agents which reverse multidrug resistance are inhibitors of vinblastine transport by isolated vesicles. Biochem. Biophys. Acta 1061:106–110 (1991).
M. Naito and T. Tsuruo. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement. Cancer Res. 49:1452–1455 (1989).
J. Hunter, B. H. Hirst, and N. L. Simmons. Transepithelial transport of vinblastine by cultured canine renal epithelia (MDCK). J. Physiol. 446:28-29P (1991).
J. A. Plumb, R. Milroy, and S. B. Kaye. The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific. Biochem. Pharmacol. 39:787–792 (1990).
F. Gueritte-Voegelain, D. Guenard, F. Lavelle, M.-T. Le Goff, L. Mangatal, and P. Potier. Relationships between the structure of taxol analogues and their antimitotic activity. J. Med. Chem. 34:992–998 (1991).
E. K. Rowinsky, L. A. Cazenave, and R. C. Donehower. Taxol: A novel investigational antimicrotubule agent. J. Natl. Cancer Inst. 82:1247–1259 (1990).
W. H. M. Peters and H. M. J. Roelofs. Biochemical characterisation of resistance to mitoxantrone and adriamycin in Caco-2 human adenocarcinoma cells: A possible role for glutathione S-transferases. Cancer Res. 52:1886–1890 (1992).
K. Gerzon, S. Ochs, and G. C. Todd. Polarity of vincristine (VCR), vindesine (VDS), and vinblastine (VLB) in relation to neurological effects. Proc. AACR Abstr. 186:46 (1979).
D. C. Tosteson and J. F. Hoffman. Regulation of cell volume by active cation transport in high and low potassium sheep red cells. J. Gen. Physiol. 44:169–194 (1960).
R. C. Sharma, S. Inoue, J. Roitelman, R. T. Schimke, and R. D. Simon. Peptide transport by the multidrug resistance pump. J. Biol. Chem. 267:5731–5734 (1992).
S. C. Hyde, P. Emsley, M. Hartshorn, M. M. Mimmack, U. Gileadi, S. R. Pearce, M. P. Gallacher, R. Hubbard, and C. F. Higgins. Structural and functional relationships associated with cystic fibrosis, multi-drug resistance and bacterial transport. Nature 346:362–365 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunter, J., Hirst, B.H. & Simmons, N.L. Drug Absorption Limited by P-Glycoprotein-Mediated Secretory Drug Transport in Human Intestinal Epithelial Caco-2 Cell Layers. Pharm Res 10, 743–749 (1993). https://doi.org/10.1023/A:1018972102702
Issue Date:
DOI: https://doi.org/10.1023/A:1018972102702